112 related articles for article (PubMed ID: 23803027)
1. Meta-analysis of associations of the ezrin gene with human osteosarcoma response to chemotherapy and prognosis.
Wang Z; He ML; Zhao JM; Qing HH; Wu Y
Asian Pac J Cancer Prev; 2013; 14(5):2753-8. PubMed ID: 23803027
[TBL] [Abstract][Full Text] [Related]
2. The association of P-glycoprotein with response to chemotherapy and clinical outcome in patients with osteosarcoma. A meta-analysis.
Pakos EE; Ioannidis JP
Cancer; 2003 Aug; 98(3):581-9. PubMed ID: 12879476
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of elevated ezrin in patients with osteosarcoma.
Lun DX; Hu YC; Xu ZW; Xu LN; Wang BW
Tumour Biol; 2014 Feb; 35(2):1263-6. PubMed ID: 24014052
[TBL] [Abstract][Full Text] [Related]
4. The clinical significance of changes in ezrin expression in osteosarcoma of children and young adults.
Lugowska I; Mierzejewska E; Lenarcik M; Klepacka T; Koch I; Michalak E; Szamotulska K
Tumour Biol; 2016 Sep; 37(9):12071-12078. PubMed ID: 27207343
[TBL] [Abstract][Full Text] [Related]
5. Immunoexpression of Ezrin and CD44 in patients with osteosarcoma.
Boldrini E; Peres SV; Morini S; de Camargo B
J Pediatr Hematol Oncol; 2010 Aug; 32(6):e213-7. PubMed ID: 20562647
[TBL] [Abstract][Full Text] [Related]
6. Correlations of ezrin expression with pathological characteristics and prognosis of osteosarcoma: a meta-analysis.
Zhao DH; Zhu J; Wang WB; Dong F; Zhang Q; Fan HW; Zhang JZ; Wang YM
ScientificWorldJournal; 2014; 2014():837543. PubMed ID: 25544963
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of TP53 tumor suppressor gene expression and mutations in human osteosarcoma: a meta-analysis.
Pakos EE; Kyzas PA; Ioannidis JP
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6208-14. PubMed ID: 15448009
[TBL] [Abstract][Full Text] [Related]
8. The Prognostic Role of Ezrin Immunoexpression in Osteosarcoma: A Meta-Analysis of Published Data.
Li H; Min D; Zhao H; Wang Z; Qi W; Zheng S; Tang L; He A; Sun Y; Yao Y; Shen Z
PLoS One; 2013; 8(6):e64513. PubMed ID: 23805177
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of immunohistochemical expression of ezrin in non-metastatic high-grade osteosarcoma.
Ferrari S; Zanella L; Alberghini M; Palmerini E; Staals E; Bacchini P
Pediatr Blood Cancer; 2008 Apr; 50(4):752-6. PubMed ID: 17886294
[TBL] [Abstract][Full Text] [Related]
10. Dose-intensive versus dose-control chemotherapy for high-grade osteosarcoma: a meta-analysis.
Wang W; Wang ZC; Shen H; Xie JJ; Lu H
Eur Rev Med Pharmacol Sci; 2014; 18(9):1383-90. PubMed ID: 24867518
[TBL] [Abstract][Full Text] [Related]
11. Ezrin and alpha-smooth muscle actin are immunohistochemical prognostic markers in conventional osteosarcomas.
Salas S; Bartoli C; Deville JL; Gaudart J; Fina F; Calisti A; Bollini G; Curvale G; Gentet JC; Duffaud F; Figarella-Branger D; Bouvier C
Virchows Arch; 2007 Dec; 451(6):999-1007. PubMed ID: 17786474
[TBL] [Abstract][Full Text] [Related]
12. Expression change of ezrin as a prognostic factor in primary osteosarcoma.
Wang YF; Shen JN; Xie XB; Wang J; Huang G
Med Oncol; 2011 Dec; 28 Suppl 1():S636-43. PubMed ID: 20859706
[TBL] [Abstract][Full Text] [Related]
13. Ezrin in osteosarcoma: comparison between conventional high-grade and central low-grade osteosarcoma.
Park HR; Jung WW; Bacchini P; Bertoni F; Kim YW; Park YK
Pathol Res Pract; 2006; 202(7):509-15. PubMed ID: 16677779
[TBL] [Abstract][Full Text] [Related]
14. Ezrin expression predicts survival in stage IIB osteosarcomas.
Kim MS; Song WS; Cho WH; Lee SY; Jeon DG
Clin Orthop Relat Res; 2007 Jun; 459():229-36. PubMed ID: 17353802
[TBL] [Abstract][Full Text] [Related]
15. microRNA-96 acts as a tumor suppressor gene in human osteosarcoma via target regulation of EZRIN.
Yao Q; Pei Y; Zhang X; Xie B
Life Sci; 2018 Jun; 203():1-11. PubMed ID: 29656060
[TBL] [Abstract][Full Text] [Related]
16. The outcomes and prognostic factors in patients with osteosarcoma according to age: a Japanese nationwide study with focusing on the age differences.
Tsuda Y; Ogura K; Shinoda Y; Kobayashi H; Tanaka S; Kawai A
BMC Cancer; 2018 May; 18(1):614. PubMed ID: 29855362
[TBL] [Abstract][Full Text] [Related]
17. Quantitative assessment of the association of COX-2 (Cyclooxygenase-2) immunoexpression with prognosis in human osteosarcoma: a meta-analysis.
Wang Z; He M; Xiao Z; Wu H; Wu Y
PLoS One; 2013; 8(12):e82907. PubMed ID: 24358237
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of p53 alterations in human osteosarcoma: a meta analysis.
Yao D; Cai GH; Chen J; Ling R; Wu SX; Li YP
Int J Clin Exp Pathol; 2014; 7(10):6725-33. PubMed ID: 25400752
[TBL] [Abstract][Full Text] [Related]
19. Role of ezrin in osteosarcoma metastasis.
Ren L; Khanna C
Adv Exp Med Biol; 2014; 804():181-201. PubMed ID: 24924175
[TBL] [Abstract][Full Text] [Related]
20. Modeling Continuous Prognostic Factors in Survival Analysis: Implications for Tumor Staging and Assessing Chemotherapy Effect in Osteosarcoma.
Cates JMM
Am J Surg Pathol; 2018 Apr; 42(4):485-491. PubMed ID: 29200101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
